Bioceres S.A: Ag Biotechnology Expansion

Roberto Feeney, Silvia Novaira


In this case we present an investment decision-making situation in which a stockholder of an Argentine Agribusiness Biotechnology company has to analyze the company’s strategy and decide if he will further invest in the firm. The company name is Bioceres; it is a fully integrated crop productivity provider in the areas of seed traits, biologicals, molecular farming and metabolic engineering. It has annual revenues of around 150 million dollars, and net losses of 10 million dollars. In the near future Bioceres will launch, at a global scale, its leading technology called HB4®, which provides drought and salinity tolerance to crops such as soybeans, alfalfa and wheat. By early 2019 Bioceres is intending to go public in the American stock market.


Business Case; Ag Biotechnology; Investment; Business Models

Full Text:



ISSN 1869-6945


This work is licensed under a Creative Commons License